4 Dividend Stalwarts I'm Buying To Start 2025

1. Procter & Gamble (PG)

• Sector: Consumer Staples
• Dividend Yield: ~2.5%
• Why Buy:
  • A classic dividend aristocrat with 67 consecutive years of dividend increases.
  • Its diversified portfolio of household brands (Tide, Gillette, Pampers) ensures steady revenue even in economic downturns.
  • Strong free cash flow supports consistent payout increases.

2. Johnson & Johnson (JNJ)

• Sector: Healthcare
• Dividend Yield: ~2.9%
• Why Buy:
  • A dividend king with 60+ years of increases, backed by its stable consumer health, pharmaceutical, and medical device divisions.
  • Healthcare spending is resilient, making J&J a defensive play during economic uncertainty.
  • Spin-off of its consumer health division (Kenvue) unlocks shareholder value while maintaining its strong dividend policy.

3. Realty Income (O)

• Sector: Real Estate (REIT)
• Dividend Yield: ~5%
• Why Buy:
  • Known as "The Monthly Dividend Company," Realty Income has a history of 119 consecutive quarterly dividend increases.
  • Its portfolio of high-quality retail and industrial properties with long-term leases provides steady income.
  • Attractive for income-focused investors seeking consistent monthly payouts.

4. AbbVie (ABBV)

• Sector: Healthcare/Pharmaceuticals
• Dividend Yield: ~4%
• Why Buy:
  • A high-yield option with strong dividend growth since its spin-off from Abbott Laboratories in 2013.
  • Robust pharmaceutical portfolio, including its immunology drugs (Humira, Rinvoq, Skyrizi), supports long-term growth.
  • Commitment to returning capital to shareholders with consistent annual increases.

Why These Picks for 2025?

• Resiliency in Market Volatility: These companies operate in sectors with steady demand, providing a buffer during economic uncertainties.
• Dividend Growth Track Record: All four have a history of increasing dividends, showing a commitment to rewarding shareholders.
• Long-Term Financial Health: Their robust balance sheets and cash flows ensure sustainable payouts.